3.0
Aug 5, 2024
Recommend
CEO approval
Business Outlook
Pros
Stable, growing, challenging work, startup culture, good office culture, sports activities, great food
Cons
Slow, less pay, no hybrid or remote work
Masimo reviews
3.3
53% would recommend to a friend
Julie Sawyer Montgomery
Not enough data to show CEO approval
53% positive business outlook
Race / Ethnicity
Gender
Sexual orientation
Disability
Parent or family caregiver
Veteran status
Aug 5, 2024
3.0
Jul 22, 2024
Great Technology, Great People…Poor Senior Leadership
Current employee, more than 8 years
Recommend
CEO approval
Business Outlook
Pros
The technology actually works. The pulse oximetry, which is the core technology, saves lives and is unquestionably the best in the market. Masimo is also one of the most innovative companies in terms of getting products out there that can make a difference in multiple care areas, and some of the new cardiovascular technology released will be well-received in multiple markets. Strategy-wise I can at least understand the consumer acquisition and crossing over to consumer health with the technology advantage — even the biggest tech giants (Apple, Samsung etc.) struggle with accurate sensors/monitoring and there’s a huge opportunity there. Middle management and people on the ground across all departments are great. They believe in what Masimo has already done, what it can continue to do and what it could still be. They’re high character, hard working people and live out the guiding principles Masimo has outlined—in many ways better than what C-level is currently doing right now. Company could have a huge growth trajectory if gets more disciplined.
Cons
Poor execution on initial product releases, healthcare or consumer. For a company trying to break into consumer healthcare/wellness it’s not paying enough attention to applications/what target audiences want outside a hospital setting. Culture changed around 2019-2020. A lot of veteran/senior leaders retired, were let go or reassigned in favor of yes men at the top. Certain C-level leaders have poor EQ and showed little respect for those who helped the CEO build the company from the ground up. CEO drives a lot of innovation and should be credited for revolutionizing pulse oximetry but power is too centralized. There’s too big an inner circle at the top, and not enough voices of reason checking the CEO. Anyone who dissents is fired or told they can go somewhere else if they don’t like it. There wasn’t enough pushback on well-intentioned but poorly researched ideas like Opioid Halo. It’s noble to want to prevent deaths like these when we have an epidemic, but CEO failed to understand the proper incentives that would convince HCPs to actually prescribe it for their patients. They’re not going to recommend if Medicare or private insurance doesn’t reimburse for it. Having inconsistent availability in offerings in different regions doesn’t help. But without proper leadership to push back on CEO, project went ahead and valuable time/money/resources were wasted. His compensation package is ludicrous, even for a founder, and everyone else’s pay relative to other industry competitors is laughable. Everyone’s on pins and needles during this activist investor fight. Not sure it’ll be good whoever comes out on top, but a lot of good people have left because management is drifting away from their guiding principles. This company is the CEO’s baby, but he forgets that it took thousands of people over the years to make it the success it is today, yet he acts like the majority are replaceable.
1.0
Jul 19, 2024
Recommend
CEO approval
Business Outlook
Pros
- Good cafeteria. - good campus.
Cons
Some teams have to work very hard and do lots of overtime. Overtime is quite normal here and expected. You don't get much in return after putting in tons of overtime. No bonus, no promotion. Just "company is not doing well financially, so we are cutting back on expenses."
Viewing 19 - 21 of 133 Reviews
